Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP784895.RAVskOar4tqsJ3K4og-oqWFCqvgUggewxEnVc4tgvGCPE130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784895.RAVskOar4tqsJ3K4og-oqWFCqvgUggewxEnVc4tgvGCPE130_provenance.
• NP802089.RAV81FDoLMMqVtANYmCrS_AH2w03UMKNLlfoHlnWR5bak130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802089.RAV81FDoLMMqVtANYmCrS_AH2w03UMKNLlfoHlnWR5bak130_provenance.
• NP540197.RAb4vxzD_PQ8wcVzk-_bHDFpdKdICKE5F4Fz_ieWDqWmY130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540197.RAb4vxzD_PQ8wcVzk-_bHDFpdKdICKE5F4Fz_ieWDqWmY130_provenance.
• NP609770.RAAdimgL_huirYBnXjtJ761ADwp_THUWg400yet_AQu-U130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609770.RAAdimgL_huirYBnXjtJ761ADwp_THUWg400yet_AQu-U130_provenance.
• NP608170.RAkurkbq4y-ZkKj0nm0oQuyaiuund3JvBmMnSKQjWEW-U130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608170.RAkurkbq4y-ZkKj0nm0oQuyaiuund3JvBmMnSKQjWEW-U130_provenance.
• NP441207.RAOWyizMRaN1IxKpHtp836YFKQgc6mV9fdzr2_7vyjI1I130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441207.RAOWyizMRaN1IxKpHtp836YFKQgc6mV9fdzr2_7vyjI1I130_provenance.
• NP741199.RAtQZi4ZeLjGF9kREeUqCohWNIU-IgTz_rSwSWjdPdbyQ130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741199.RAtQZi4ZeLjGF9kREeUqCohWNIU-IgTz_rSwSWjdPdbyQ130_provenance.
• NP170852.RA3rfi3_S05sekklI5E0DIgAmnTXZ2YAGbWcfX9Yr70ds130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170852.RA3rfi3_S05sekklI5E0DIgAmnTXZ2YAGbWcfX9Yr70ds130_provenance.
• NP789753.RADFpssLgUuO0SNZWMnGCAo-VilvdutB3hZAcs_6h8Me8130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789753.RADFpssLgUuO0SNZWMnGCAo-VilvdutB3hZAcs_6h8Me8130_provenance.
• NP792462.RAALDA7FlYmPPZoa-EG8YHndesEuaBMBi3WuV-RsVwH_w130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792462.RAALDA7FlYmPPZoa-EG8YHndesEuaBMBi3WuV-RsVwH_w130_provenance.
• NP360801.RA-Hbf9ZUyjDHHYpSx-JHfy8waQO-1bdtoEKaLO9VS2yM130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360801.RA-Hbf9ZUyjDHHYpSx-JHfy8waQO-1bdtoEKaLO9VS2yM130_provenance.
• NP520849.RA2AXyO9FFdCiWYhYoPkOnipSsB36wFWaY7K88qqfOAHE130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520849.RA2AXyO9FFdCiWYhYoPkOnipSsB36wFWaY7K88qqfOAHE130_provenance.
• assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP622050.RA9yNWYS2jL9gqOLVPvYgUqYjz_BwboJKWgzHixh3j8-4130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622050.RA9yNWYS2jL9gqOLVPvYgUqYjz_BwboJKWgzHixh3j8-4130_provenance.
• NP622053.RA73FBmovHCWvxjIBGYWqt4n3IVjbAVWOB4RROz7kRghY130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622053.RA73FBmovHCWvxjIBGYWqt4n3IVjbAVWOB4RROz7kRghY130_provenance.
• NP360989.RAJUbV-FvTBIHZGFBT1oJDpJv0TtmwRGdULXlQqytr7_o130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360989.RAJUbV-FvTBIHZGFBT1oJDpJv0TtmwRGdULXlQqytr7_o130_provenance.
• NP622049.RAV_XnhaPwlTGYzC7XRg4DMAuBEPh6tJuj9NGnCOmR9g4130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622049.RAV_XnhaPwlTGYzC7XRg4DMAuBEPh6tJuj9NGnCOmR9g4130_provenance.
• NP622051.RAbYJVjm29U7joiHlX6ArfOkAAeWnVBmT4CEdyGw9oh5w130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622051.RAbYJVjm29U7joiHlX6ArfOkAAeWnVBmT4CEdyGw9oh5w130_provenance.
• NP622052.RAlD9KOuuxFvEzqI-_CeowBda0JDZzKxEOD-WLnvjyCAw130_assertion description "[We describe a new model of myeloma bone disease in which beta2m NOD/SCID mice injected with KMS-12-BM cells develop medullary disease after tail vein administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622052.RAlD9KOuuxFvEzqI-_CeowBda0JDZzKxEOD-WLnvjyCAw130_provenance.